Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$911M |
| 2 |
Palo Alto Networks
PANW
|
+$888M |
| 3 |
Colgate-Palmolive
CL
|
+$406M |
| 4 |
Medtronic
MDT
|
+$383M |
| 5 |
Pinterest
PINS
|
+$366M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.27B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$896M |
| 3 |
Apple
AAPL
|
+$764M |
| 4 |
Meta Platforms (Facebook)
META
|
+$585M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$564M |
Sector Composition
| 1 | Technology | 23.49% |
| 2 | Financials | 13.29% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Communication Services | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMBR
3726
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $33K | ﹤0.01% |
2,072
+1,000
| +93% | +$15.9K |
|
3727
Acumen Pharmaceuticals
ABOS
$78.7M
| $32K | ﹤0.01% |
6,724
-5,093
| -43% | -$24.2K |
|
3728
Enact Holdings
ACT
$5.74B
| $32K | ﹤0.01% |
1,507
-893
| -37% | -$19K |
|
3729
BioXcel Therapeutics
BTAI
$49.9M
| $32K | ﹤0.01% |
152
-29
| -16% | -$6.11K |
|
3730
Crescent Energy
CRGY
$2.21B
| $32K | ﹤0.01% |
2,630
-28,876
| -92% | -$351K |
|
|
FPI
3731
Farmland Partners
FPI
$481M
| $32K | ﹤0.01% |
2,298
-2,349
| -51% | -$32.7K |
|
3732
Microvision
MVIS
$340M
| $32K | ﹤0.01% |
8,311
-19,133
| -70% | -$73.7K |
|
3733
Passage Bio
PASG
$22.3M
| $32K | ﹤0.01% |
678
-319
| -32% | -$15.1K |
|
3734
Root
ROOT
$1.53B
| $32K | ﹤0.01% |
1,523
+261
| +21% | +$5.48K |
|
|
SHYF
3735
DELISTED
The Shyft Group
SHYF
| $32K | ﹤0.01% |
1,732
-4,288
| -71% | -$79.2K |
|
3736
Sterling Infrastructure
STRL
$9.55B
| $32K | ﹤0.01% |
1,470
-20,190
| -93% | -$440K |
|
|
NESR
3737
National Energy Services Reunited Corp. Ordinary Shares
NESR
$1.02B
| $32K | ﹤0.01% |
4,649
-7,672
| -62% | -$52.8K |
|
|
ESTE
3738
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $32K | ﹤0.01% |
2,291
-2,741
| -54% | -$38.3K |
|
3739
Backblaze
BLZE
$534M
| $31K | ﹤0.01% |
5,845
| – | – |
|
3740
Berry Corp
BRY
$257M
| $31K | ﹤0.01% |
4,023
-6,926
| -63% | -$53.4K |
|
3741
iShares MSCI Mexico ETF
EWW
$1.92B
| $31K | ﹤0.01% |
658
-39,693
| -98% | -$1.87M |
|
3742
iShares Convertible Bond ETF
ICVT
$2.88B
| $31K | ﹤0.01% |
450
| – | – |
|
|
INZY
3743
DELISTED
Inozyme Pharma
INZY
| $31K | ﹤0.01% |
6,403
-2,337
| -27% | -$11.3K |
|
3744
Vanguard S&P Mid-Cap 400 ETF
IVOO
$2.81B
| $31K | ﹤0.01% |
+400
| New | +$31K |
|
3745
OrthoPediatrics
KIDS
$493M
| $31K | ﹤0.01% |
723
-1,587
| -69% | -$68K |
|
3746
MediaAlpha
MAX
$689M
| $31K | ﹤0.01% |
3,091
-2,323
| -43% | -$23.3K |
|
3747
Quanterix
QTRX
$223M
| $31K | ﹤0.01% |
1,862
-3,385
| -65% | -$56.4K |
|
3748
Replimune Group
REPL
$447M
| $31K | ﹤0.01% |
1,826
-3,425
| -65% | -$58.1K |
|
3749
UroGen Pharma
URGN
$869M
| $31K | ﹤0.01% |
3,782
-3,169
| -46% | -$26K |
|
|
GLLI
3750
DELISTED
Globalink Investment Inc. Common Stock
GLLI
| $31K | ﹤0.01% |
+3,102
| New | +$31K |
|